Predictors of Nicotine Replacement Therapy Adherence: Mixed-Methods Research With a Convergent Parallel Design
CONCLUSIONS: Individuals who have negative attitudes toward NRT are less likely to use the products in a smoking cessation intervention. Counselors should assess attitudes toward NRT at baseline and address them proactively during counseling sessions.PMID:38401531 | DOI:10.1093/abm/kaae006 (Source: Annals of Behavioral Medicine)
Source: Annals of Behavioral Medicine - February 24, 2024 Category: Psychiatry & Psychology Authors: Sun S Kim Anyah Prasad Manan M Nayak Hua Chen Chaowalit Srisoem Rosanna F DeMarco Peter Castaldi Mary E Cooley Source Type: research

Electronic Cigarettes for Smoking Cessation —A Clinician’s Dilemma
The randomized clinical trial by Lin et al in this issue of JAMA Internal Medicine demonstrated that participants randomized to nicotine electronic cigarettes (ECs) experienced greater sustained smoking abstinence at 6 months than participants randomized to medicinal nicotine gum and similar (noninferior) sustained abstinence to participants randomized to varenicline (Chantix; Pfizer), a partial nicotinic receptor agonist. Notably, the study, conducted in China with 1068 participants, compared only a single form of nicotine replacement therapy (NRT) rather than 2 NRT forms in combination (eg, patch plus gum or lozenge), wh...
Source: JAMA Internal Medicine - January 29, 2024 Category: Internal Medicine Source Type: research

Efficacy of Electronic Cigarettes vs Varenicline and Nicotine Chewing Gum as an Aid to Stop Smoking
This randomized clinical trial examines whether electronic cigarettes are superior to nicotine replacement therapy and noninferior to varenicline in helping smokers quit. (Source: JAMA Internal Medicine)
Source: JAMA Internal Medicine - January 29, 2024 Category: Internal Medicine Source Type: research

Is Abstinence from Alcohol and Smoking Associated with Less Anxiety and Depressive Symptoms Among People with HIV?
AbstractAchieving abstinence from alcohol, tobacco, or both may improve mental health, but is understudied in people with HIV (PWH). The St PETER HIV randomized clinical trial compared varenicline, cytisine, and nicotine replacement therapy on alcohol and smoking behavior among 400 PWH in Russia. The primary exposure was thirty-day point prevalence abstinence (PPA) from (1) alcohol, (2) smoking, (3) both, or (4) neither and was assessed at 1, 3, 6 and 12-months as were the study outcomes of anxiety (GAD-7) and depressive (CES-D) symptoms. The primary aim was to examine the association between smoking and/or alcohol abstine...
Source: AIDS and Behavior - January 29, 2024 Category: Infectious Diseases Source Type: research

Addiction and Liver Disease: Exploring the Complex Relationship and Implications for Clinical Management
AbstractPurpose of ReviewThe review focuses on addressing substance use disorders in individuals with chronic liver disease, specifically alcohol, tobacco, and cannabis.Recent FindingsPsychological interventions and medications like naltrexone and acamprosate are effective in treating alcohol use disorder in patients with liver disease. Tobacco smoking has a negative impact on fibrosis progression, it is recommended to regularly screen and provide structured brief interventions in combination with medications like varenicline and nicotine replacement therapy. Cannabis use disorder is associated with adverse health outcomes...
Source: Current Hepatitis Reports - January 23, 2024 Category: Infectious Diseases Source Type: research

A phone-based tobacco use cessation program for people living with HIV in Uganda and Zambia: study protocol for a randomized controlled trial
DISCUSSION: Our study will provide insight into the efficacy, feasibility and applicability of delivering tobacco cessation interventions through health care professionals combined with tailored tobacco cessation SMS text messaging in two countries with different tobacco use patterns, policy environments, and health care resources and provide needed information to providers and policymakers looking for cost-effective tobacco cessation interventions. The previously tested SMS-platform to be used in our study is uniquely positioned to be scaled in low- and middle-income countries worldwide, in which case evidence of even mod...
Source: Addiction Science and Clinical Practice - January 19, 2024 Category: Addiction Authors: Heather Wipfli Jim Arinaitwe Fastone Goma Lynn Atuyambe David Guwatudde Masauso Moses Phiri Elizeus Rutebemberwa Fred Wabwire-Mangen Richard Zulu Cosmas Zyambo Kyra Guy Ronald Kusolo Musawa Mukupa Ezekiel Musasizi Joan S Tucker Source Type: research

Electronic cigarettes for smoking cessation
CONCLUSIONS: There is high-certainty evidence that ECs with nicotine increase quit rates compared to NRT and moderate-certainty evidence that they increase quit rates compared to ECs without nicotine. Evidence comparing nicotine EC with usual care/no treatment also suggests benefit, but is less certain due to risk of bias inherent in the study design. Confidence intervals were for the most part wide for data on AEs, SAEs and other safety markers, with no difference in AEs between nicotine and non-nicotine ECs nor between nicotine ECs and NRT. Overall incidence of SAEs was low across all study arms. We did not detect eviden...
Source: Cochrane Database of Systematic Reviews - January 8, 2024 Category: General Medicine Authors: Nicola Lindson Ailsa R Butler Hayden McRobbie Chris Bullen Peter Hajek Rachna Begh Annika Theodoulou Caitlin Notley Nancy A Rigotti Tari Turner Jonathan Livingstone-Banks Tom Morris Jamie Hartmann-Boyce Source Type: research

Type-switching of short-acting nicotine replacement therapy products and its implications for treatment
The frequency with which people change from one medical treatment to another partly reflects satisfaction with the initial intervention. In this secondary analysis of observational data, we explore switch rates for short-acting nicotine replacement therapy (NRT) products, which differ in mode of use, rapidity of action, and adverse effect profiles. (Source: Journal of Substance Abuse Treatment)
Source: Journal of Substance Abuse Treatment - December 29, 2023 Category: Addiction Authors: Scott Veldhuizen, Laurie Zawertailo, Peter Selby Source Type: research

Combining interactive communication and nicotine replacement therapy for smokers: abridged secondary publication
Hong Kong Med J. 2023 Dec;29 Suppl 7(6):4-8.NO ABSTRACTPMID:38148648 (Source: Hong Kong Med J)
Source: Hong Kong Med J - December 27, 2023 Category: General Medicine Authors: M P Wang T H Lam K Viswanath R C K Cheng T T O Kwok D Y T Cheung C K H Wong J J J Lee H C H Chan Source Type: research

Combining interactive communication and nicotine replacement therapy for smokers: abridged secondary publication
Hong Kong Med J. 2023 Dec;29 Suppl 7(6):4-8.NO ABSTRACTPMID:38148648 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - December 27, 2023 Category: General Medicine Authors: M P Wang T H Lam K Viswanath R C K Cheng T T O Kwok D Y T Cheung C K H Wong J J J Lee H C H Chan Source Type: research

Combining interactive communication and nicotine replacement therapy for smokers: abridged secondary publication
Hong Kong Med J. 2023 Dec;29 Suppl 7(6):4-8.NO ABSTRACTPMID:38148648 (Source: Hong Kong Med J)
Source: Hong Kong Med J - December 27, 2023 Category: General Medicine Authors: M P Wang T H Lam K Viswanath R C K Cheng T T O Kwok D Y T Cheung C K H Wong J J J Lee H C H Chan Source Type: research

Combining interactive communication and nicotine replacement therapy for smokers: abridged secondary publication
Hong Kong Med J. 2023 Dec;29 Suppl 7(6):4-8.NO ABSTRACTPMID:38148648 (Source: Hong Kong Medical Journal)
Source: Hong Kong Medical Journal - December 27, 2023 Category: General Medicine Authors: M P Wang T H Lam K Viswanath R C K Cheng T T O Kwok D Y T Cheung C K H Wong J J J Lee H C H Chan Source Type: research

Effects of different combined behavioral and pharmacological interventions on smoking cessation: a network meta-analysis of 103 randomized controlled trials
ConclusionsAmong combined interventions for smoking cessation, Varenicline + CBT, NRT + CBT + Financial incentive, and Bupropion + CBT demonstrate the highest levels of success. CBT, FI, and Varenicline are potential intervention components that may possess greater effectiveness. (Source: Journal of Public Health)
Source: Journal of Public Health - December 21, 2023 Category: Health Management Source Type: research

Use of nicotine replacement therapy to reduce children ’s exposure to second-hand smoke in the home: a qualitative pilot study involving local community pharmacies
In Scotland, and in several other countries, most second-hand smoke exposure now occurs in low-income households, where housing constraints and sole parenting often make it harder to create a smoke-free home. ... (Source: BMC Public Health)
Source: BMC Public Health - December 20, 2023 Category: Consumer Health News Authors: Rebecca Howell, Stephen McBurney, Giovanna Di Tano, Aileen Boags, Neneh Rowa-Dewar, Ruaraidh Dobson and Rachel O ’Donnell Tags: Research Source Type: research

Assessment of knowledge, attitude and practices of tobacco cessation counselling and nicotine replacement therapy among dental professionals
CONCLUSION: Inclusion of TCC in the undergraduate curriculum, training and updating of dental faculty and students regarding TCC and NRT will help in serving the noble cause.PMID:38074232 | PMC:PMC10706537 | DOI:10.4103/jfmpc.jfmpc_586_23 (Source: Primary Care)
Source: Primary Care - December 11, 2023 Category: Primary Care Authors: Anagha V Shete Mrinal V Shete Ashwini Nerkar Rajbhoj Ladusingh Rajpurohit Arti Hajarnavis Abhijeet Sande Source Type: research